A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : SCW / streptococcal cell wall

[Related PubMed/MEDLINE]
Total Number of Papers: 104
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   SCW  (>> Co-occurring Abbreviation)
Long Form:   streptococcal cell wall
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Type II collagen peptide Coll2-1 is an actor of synovitis. IA, IL, ROS, s.c, VEGF
2018 The involvement of Toll-like receptor 9 in the pathogenesis of erosive autoimmune arthritis. PIA, RA, TLR
2016 Anti-Inflammatory Effects of the Essential Oils of Ginger (Zingiber officinale Roscoe) in Experimental Rheumatoid Arthritis. GEO
2015 Disease-regulated local IL-10 gene therapy diminishes synovitis and cartilage proteoglycan depletion in experimental arthritis. IL-10
2014 Etanercept ameliorates inflammation and pain in a novel mono-arthritic multi-flare model of streptococcal cell wall induced arthritis. ---
2014 Interleukin-21 receptor deficiency increases the initial toll-like receptor 2 response but protects against joint pathology by reducing Th1 and Th17 cells during streptococcal cell wall arthritis. AIA, IFN-gamma, IL-21, SOCS-1, TLR2
2014 Targeting the P2X7 receptor in rheumatoid arthritis: biological rationale for P2X7 antagonism. BzATP, IL, LPS
2012 Destructive role of myeloid differentiation factor 88 and protective role of TRIF in interleukin-17-dependent arthritis in mice. IL-17, MyD88, TLRs
2011 A novel Saa3-promoter reporter distinguishes inflammatory subtypes in experimental arthritis and human synovial fibroblasts. Luc, LV, OA, RA, SAA3, SF, Tc, TLR
10  2011 Rodent preclinical models for developing novel antiarthritic molecules: comparative biology and preferred methods for evaluating efficacy. AIA, CIA, RA, RMIA
11  2010 A crucial role for tumor necrosis factor receptor 1 in synovial lining cells and the reticuloendothelial system in mediating experimental arthritis. CIA, IFN, IL, NF-kappaB, qPCR, RA, RES, sh, SLC, TNF, TNFR1
12  2010 Anti-arthritic effects and toxicity of the essential oils of turmeric (Curcuma longa L.). RA, TEO
13  2010 Role of interleukin 17 in arthritis chronicity through survival of synoviocytes via regulation of synoviolin expression. IL-17RA, IL-17RC, RA, siRNA, SNP
14  2009 Apoptotic cell-mediated suppression of streptococcal cell wall-induced arthritis is associated with alteration of macrophage function and local regulatory T-cell increase: a potential cell-based therapy? ---
15  2009 Combined blockade of granulocyte-macrophage colony stimulating factor and interleukin 17 pathways potently suppresses chronic destructive arthritis in a tumour necrosis factor alpha-independent mouse model. GM-CSF, IL, KO, RA, TNF, WT
16  2008 Shift from toll-like receptor 2 (TLR-2) toward TLR-4 dependency in the erosive stage of chronic streptococcal cell wall arthritis coincident with TLR-4-mediated interleukin-17 production. IL-1, MMP, RA, TLR2, TLRs
17  2008 T cell dependence of chronic destructive murine arthritis induced by repeated local activation of Toll-like receptor-driven pathways: crucial role of both interleukin-1beta and interleukin-17. IA, IL-17, TNF-alpha
18  2008 The molecular signature of oxidative metabolism and the mode of macrophage activation determine the shift from acute to chronic disease in experimental arthritis: critical role of interleukin-12p40. IL-1beta, iNOS
19  2007 Disease modifying effects of N-butyryl glucosamine in a streptococcal cell wall induced arthritis model in rats. BMD
20  2007 GM-CSF neutralisation suppresses inflammation and protects cartilage in acute streptococcal cell wall arthritis of mice. GM-CSF, TNF
21  2006 Inhibition of p38 mitogen-activated protein kinase prevents inflammatory bone destruction. MAPK, NF, OCL, RA, TNF
22  2006 Turmeric extracts containing curcuminoids prevent experimental rheumatoid arthritis. RA
23  2005 Animal models of rheumatoid arthritis and their relevance to human disease. CIA, RA
24  2005 Gene expression profiles in the rat streptococcal cell wall-induced arthritis model identified using microarray analysis. RA
25  2005 Induction of cartilage damage by overexpression of T cell interleukin-17A in experimental arthritis in mice deficient in interleukin-1. IL-17A, MMPs, PG
26  2005 Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis. IL-17R, MMPs, PCR, WT
27  2004 An inflammation-inducible adenoviral expression system for local treatment of the arthritic joint. Luc
28  2004 Joint cytokine quantification in two rodent arthritis models: kinetics of expression, correlation of mRNA and protein levels and response to prednisolone treatment. CIA, ELISA, PCR, RA
29  2003 Blockade of parathyroid hormone-related protein prevents joint destruction and granuloma formation in streptococcal cell wall-induced arthritis. PTHrP, RA
30  2003 Citrullination of synovial proteins in murine models of rheumatoid arthritis. anti-CCP, CIA, ELISA, mRNA, PAD, PAD2, RA
31  2003 Nitric oxide in experimental joint inflammation. Benefit or detriment? eNOS, iNOS, nNOS, NO
32  2003 Splenectomy attenuates streptococcal cell wall-induced arthritis and alters leukocyte activation. IL-1beta, NO, PG-PS
33  2003 Streptococcal cell wall induced arthritis: leukocyte activation in extra-articular lymphoid tissue. RA
34  2003 Toll-like receptor 2 pathway drives streptococcal cell wall-induced joint inflammation: critical role of myeloid differentiation factor 88. MyD88, TLR
35  2002 Intraarticular gene transfer of TNFR:Fc suppresses experimental arthritis with reduced systemic distribution of the gene product. RA, rAAV, TNF-alpha, TNFR
36  2002 Local interleukin-12 gene transfer promotes conversion of an acute arthritis to a chronic destructive arthritis. IL-12, PG
37  2001 Streptococcal cell wall arthritis. RA, SCW PG-PS
38  2001 Suppression of chronic streptococcal cell wall-induced arthritis in Lewis rats by liposomal clodronate. IL, MMP-9, SUVc, TNF-alpha
39  2001 The discovery of RPR 200765A, a p38 MAP kinase inhibitor displaying a good oral anti-arthritic efficacy. LPS, RA, TNF
40  2000 An IFN-gamma-independent proinflammatory role of IL-18 in murine streptococcal cell wall arthritis. ---
41  2000 Blockade of endogenous interleukin 12 results in suppression of murine streptococcal cell wall arthritis by enhancement of interleukin 10 and interleukin 1Ra. IL-12
42  2000 Oral buprenorphine is anti-inflammatory and modulates the pathogenesis of streptococcal cell wall polymer-induced arthritis in the Lew/SSN rat. s.c
43  2000 Superoxide release and superoxide dismutase expression by human gingival fibroblasts. CuZnSOD, LPS, MnSOD, SOD, TNF
44  2000 Suppression of streptococcal cell wall-induced arthritis by human chorionic gonadotropin. hCG, IL-6, iNOS
45  2000 The eicosapentaenoic to docosahexaenoic acid ratio of diets affects the pathogenesis of arthritis in Lew/SSN rats. BT, DHA, EPA, SFO
46  1999 Effects of the phosphodiesterase inhibitor rolipram on streptococcal cell wall-induced arthritis in rats. beta-AR, DTH, PDE IV
47  1999 Immune complexes, but not streptococcal cell walls or zymosan, cause chronic arthritis in mouse strains susceptible for collagen type II auto-immune arthritis. CIA, IC, ICA
48  1999 Inhibition of bacterial cell wall-induced leukocyte recruitment and hepatic granuloma formation by TGF-beta gene transfer. ---
49  1999 Secretory leukocyte protease inhibitor suppresses the inflammation and joint damage of bacterial cell wall-induced arthritis. SLPI
50  1998 A novel endogenous corticotropin release inhibiting factor. CRIF, RA, TRH
51  1998 Adrenergic regulation of macrophage-derived tumor necrosis factor-alpha generation during a chronic polyarthritis pain model. CFA
52  1998 Different roles of tumour necrosis factor alpha and interleukin 1 in murine streptococcal cell wall arthritis. IL-1, IL-1ra, TNF-alpha, TNFbp
53  1998 NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. FasL, RA, TNF-alpha
54  1998 Oral delivery of group A streptococcal cell walls augments circulating TGF-beta and suppresses streptococcal cell wall arthritis. ---
55  1998 Regulatory role of interleukin 10 in joint inflammation and cartilage destruction in murine streptococcal cell wall (SCW) arthritis. More therapeutic benefit with IL-4/IL-10 combination therapy than with IL-10 treatment alone. IL-10, TNF-alpha
56  1998 Role of chemokines and cytokines in a reactivation model of arthritis in rats induced by injection with streptococcal cell walls. IL-1, MCP-1, TNF-alpha
57  1997 Thyroxine administration prevents streptococcal cell wall-induced inflammatory responses. mRNA
58  1996 Streptococcal cysteine protease augments lung injury induced by products of group A streptococci. BAL, SCP, SLO
59  1995 Yersinia-associated arthritis in rats: effect of 65 kDa heat shock protein, bovine serum albumin and incomplete Freund's adjuvant. BSA, HSP, IFA
60  1993 Coexpression of phosphotyrosine-containing proteins, platelet-derived growth factor-B, and fibroblast growth factor-1 in situ in synovial tissues of patients with rheumatoid arthritis and Lewis rats with adjuvant or streptococcal cell wall arthritis. AA, FGF, OA
61  1993 Generation of a novel CD8+ cytotoxic T lymphocyte that requires soluble factor to lyse autologous antigen-presenting cells. B-LCL
62  1993 [Analysis of autoreactive CD8+ T cells against antigen presenting cells]. B-LCL, SFCA
63  1993 [Experimental epithelioid cell granuloma formation in Lewis rats induced by injection of cell wall fragments derived from alpha-streptococcus--etiologic relationship between bacterial cell wall and sarcoid granuloma]. ---
64  1993 [Generation of a monoclonal antibody specific to human T cell receptor V beta 22, and analysis of peripheral blood T cell repertoire utilizing this monoclonal antibody]. ---
65  1992 Arthritis-susceptible Lewis rats fail to emerge from the stress hyporesponsive period. CORT, CRH, HPA, HSD, PVN
66  1992 Corticotropin releasing hormone related behavioral and neuroendocrine responses to stress in Lewis and Fischer rats. ACTH, CRH, HPA
67  1992 Gut flora induces and maintains resistance against streptococcal cell wall-induced arthritis in F344 rats. ---
68  1992 Immunomodulation of streptococcal cell wall-induced arthritis. Identification of inflammatory cells and regulatory T cell subsets by mercuric chloride and in vivo CD8 depletion. ---
69  1992 In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis. COX, OA, PG, RA
70  1992 Kupffer cells express type I TGF-beta receptors, migrate to TGF-beta and participate in streptococcal cell wall induced hepatic granuloma formation. ---
71  1992 Neurotransmitter-induced hypothalamic-pituitary-adrenal axis responsiveness is defective in inflammatory disease-susceptible Lewis rats: in vivo and in vitro studies suggesting globally defective hypothalamic secretion of corticotropin-releasing hormone. ACh, HPA, iCRH, NE
72  1992 Role of Kupffer cells in developing streptococcal cell wall granulomas. Streptococcal cell wall induction of inflammatory cytokines and mediators. IL-1, PGE2, TGF-beta, TNF-alpha
73  1992 Treatment of rats with monoclonal anti-CD4 induces long-term resistance to streptococcal cell wall-induced arthritis. AA
74  1991 Endothelial cells and the pathogenesis of rheumatoid arthritis in humans and streptococcal cell wall arthritis in Lewis rats. IL-1, PDGF, RA, TGF-beta
75  1991 HLA-DQ-restricted CD4+ T cells specific to streptococcal antigen present in low but not in high responders. DQw3, DQw4
76  1991 IFN-gamma inhibits inflammatory cell recruitment and the evolution of bacterial cell wall-induced arthritis. ---
77  1991 Inhibitors of reactive oxygen intermediates suppress bacterial cell wall-induced arthritis. LEW, ROI
78  1991 Streptococcal cell wall-induced arthritis and adjuvant arthritis in F344----Lewis and in Lewis----F344 bone marrow chimeras. AA
79  1991 Transforming growth factor beta 1 suppresses acute and chronic arthritis in experimental animals. ---
80  1990 Cytokines and growth regulation of synoviocytes from patients with rheumatoid arthritis and rats with streptococcal cell wall arthritis. RA
81  1990 Detection of high levels of heparin binding growth factor-1 (acidic fibroblast growth factor) in inflammatory arthritic joints. FGF, HBGF, OA, RA
82  1990 Expression of the human MHC, HLA-DQW6 genes alters the immune response in C57BL/6 mice. ---
83  1990 Flare-up reaction of streptococcal cell wall induced arthritis in Lewis and F344 rats: the role of T lymphocytes. ---
84  1990 HLA-linked immune suppression genes. ---
85  1990 In situ expression of transforming growth factor beta in streptococcal cell wall-induced granulomatous inflammation and hepatic fibrosis. i.p, TGF-beta
86  1990 [CD4+T cells restricted by DQ not by DR support CD8+T cells to grow]. ---
87  1989 A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. CRH, HPA
88  1989 Anchorage-independent growth of synoviocytes from arthritic and normal joints. Stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-beta and retinoids. EGF, IFN-gamma, IL-1, PDGF, TGF-beta, TNF-alpha
89  1989 HLA-linked immune suppression in humans. APC, Ir-genes, Is-genes, ML
90  1989 Protection against streptococcal cell wall-induced arthritis by pretreatment with the 65-kD mycobacterial heat shock protein. ---
91  1989 Streptococcal cell wall-induced polyarthritis in the rat. Mechanisms for chronicity and regulation of susceptibility. GF
92  1989 Transforming growth factor-beta production by synovial tissues from rheumatoid patients and streptococcal cell wall arthritic rats. Studies on secretion by synovial fibroblast-like cells and immunohistologic localization. TGF-beta
93  1989 Transin/stromelysin expression in the synovium of rats with experimental erosive arthritis. In situ localization and kinetics of expression of the transformation-associated metalloproteinase in euthymic and athymic Lewis rats. ---
94  1988 Bacterial cell wall-induced immunosuppression. Role of transforming growth factor beta. TGF-beta
95  1988 Streptococcal cell wall-induced arthritis and flare-up reaction in mice induced by homologous or heterologous cell walls. ---
96  1988 T cell responses to streptococcal antigens in rats: relation to susceptibility to streptococcal cell wall-induced arthritis. ---
97  1987 Interactive effect of Gm and Km allotypes on cellular immune responses to streptococcal cell wall antigen. ---
98  1987 Variable severity and Ia antigen expression in streptococcal-cell-wall-induced hepatic granulomas in rats. Ia
99  1986 Bacterial cell wall-induced hepatic granulomas. An in vivo model of T cell-dependent fibrosis. CsA, FAF
100  1986 Functional and molecular analysis of three distinct HLA-DR4 beta-chains responsible for the MLR between HLA-Dw4, Dw15, and DKT2. APC, B-LCL, MLR, PBL